A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

Part of paid clinical trials in Chandler, Arizona.

Sponsor
Bristol-Myers Squibb
Study ID
NCT07763418
Phase
PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Kidney Failure, Chronic

Eligibility Criteria

Sex
ALL
Age
18 Years - 84 Years
Healthy Volunteers
Accepted

Interventions

Study Details

The purpose of this study is to assess the pharmacokinetics and safety of golcadomide (BMS-986369) in matched healthy participants with normal renal function, adult participants with severe renal impairment, and participants with end-stage renal disease.

Key Dates

First listed
Aug 13, 2026
Start date
Aug 24, 2026
Status verified
Aug 2026
Primary completion
Dec 14, 2026
Completion
Dec 28, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Group A
  • Experimental: Group B
  • Experimental: Group C

Primary Outcome Measure

Maximum observed concentration (Cmax) [ Time Frame: Up to Day 44 ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (3)

FacilityCityStateZIPSite coordinators
Local Institution - 0003ChandlerArizona85225
Site 0003
Local Institution - 0002Miami LakesFlorida33014
Site 0002
Local Institution - 0001OrlandoFlorida32809-3017
Site 0001

Find similar trials in Chandler, AZ

By research site
Local Institution - 0003· Chandler, AZLocal Institution - 0002· Miami Lakes, FLLocal Institution - 0001· Orlando, FL

Related Studies